City
Epaper

India gets largest PE investment in healthcare sector in Asia-Pacific region during 2024: Report

By ANI | Updated: April 23, 2025 11:42 IST

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the ...

Open in App

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the largest private equity buyout in the healthcare sector in the Asia-Pacific region in 2024, said a report by the global private investment firm Bain and Capital.

The wider Asia-Pacific market, however, grapples with a decline in buyout activity, with regional volumes plummeting by nearly 49 per cent.

"India also appears more resilient to deal downturns than other countries in the region, with buyout volumes dipping only 18 per cent from 2023, vs. a nearly 49 percent drop across Asia-Pacific overall", said the report

This growth can be attributed to a combination of buoyant capital markets, strong economic fundamentals, and a burgeoning investor confidence, fuelled by successful private equity exits, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma.

"Successful PE exits with strong returns, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma, have also validated India's buyout market, making it more attractive for future investment," the report added.

Strong growth is projected to continue in India's healthcare sector, with healthcare spending expected to reach USD 320 billion by 2028.

In India, over the past two years, investments have come in the provider and related services space and biopharma and related services, with a sharper focus on provider deals. In the provider space, investments have gravitated to hospitals, clinics, and supporting services.

The report highlighted that the India has consistently delivered favourable returns and has enabled a range of successful exits for PE firms through initial public offerings (boosted by strong public markets), strategic acquisitions (bolstered by acquirers' strong balance sheets), and sponsor-to-sponsor deals (such as KKR's USD 839 million acquisition of Healthium Medtech from Apax Funds).

"With a proven track record, favourable macroeconomic conditions, and a diverse healthcare landscape, India is expected to remain a prime investment location for PE firms," the report added.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalPakistan International Airlines in pickle as bidder exits privatisation race

NationalCBI begins probe into ‘mysterious’ death of Delhi hotel management graduate in 2017

Cricket"Abhishek Nayar knows every cricketer on the planet": KKR assistant coach Shane Watson

EntertainmentPen, Paper and Tears: Malayalam Cinema bids emotional farewell to Sreenivasan

NationalSecurity forces foil major Maoist plot in Chhattisgarh

Business Realted Stories

BusinessNo changes in existing rules for short selling: SEBI

BusinessPetroleum and Natural Gas Rules 2025 to bring paradigm shift in oil & gas sector: Hardeep Puri

Business‘Greatest gift for Assam’: Leaders and commoners praise PM Modi over Namrup urea plant

BusinessTripura Gramin Bank leads in implementing PM Modi's flagship schemes with last-mile focus: Officials

BusinessEVs driving India's growth in clean mobility & jobs: Minister